- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Litigation Support Services
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Disputes
-
May 10, 2021Robins Kaplan Appointed Interim Lead Counsel in Antitrust Class Action Against Martin Shkreli and His Former Companies
-
May 7, 2021Robins Kaplan Attorneys Nominated for Antitrust Writing Awards 2021
-
April 26, 2021Amy Churan Named to L.A. Business Journal’s “Women of Influence” List
-
May 17, 2021Practice Pointers for Virtual Hearings
-
May 19, 2021Minnesota IP Law Association (MIPLA) Virtual Stampede
-
May 20, 20219TH Annual Seeds of Change Golf Tournament
-
May 5, 2021Bio-Rad Ruling Highlights IP Assignment Clause Limits
-
May 3, 2021Maintain A Foothold
-
April 20, 2021Copyright Concerns For NFT Buyers, Sellers In Music Industry
-
May 11, 2021Financial Daily Dose 5.11.2021 | Top Story: FBI Identifies Hackers Behind Pipeline Attack
-
May 10, 2021Financial Daily Dose 5.10.2021 | Top Story: Ransomware Attack Prompts Closure of Key U.S. Pipeline
-
May 7, 2021Financial Daily Dose 5.7.2021 | Top Story: Improving Unemployment Figures Buoys Hopes for Strong April Jobs Report
Invokana and Farxiga
You must read the following notice before sending an e-mail message to Robins Kaplan LLP.
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
For further inquiries about Invokanaand Farxiga, feel free to call us toll free at 1.800.553.9910, or send an e-mail by clicking on this link: contact us.
Invokana, Farxiga, and other related type 2 diabetes drugs have been linked to a serious condition known as ketoacidosis.
Diabetes Drug Update – Invokana and Farxiga
In May 2015, the FDA issued a Safety Communication advising that certain Type 2 Diabetes drugs may result in a serious condition known as ketoacidosis.
Holly Dolejsi of Robins Kaplan LLP Appointed Co-Lead Counsel in Farxiga Multidistrict Litigation
Judge Lorna G. Schofield has appointed Robins Kaplan attorney Holly Dolejsi as co-lead counsel in multidistrict litigation (MDL) involving the diabetes drug Farxiga.
Robins Kaplan LLP Investigates Type 2 Diabetes Drugs and Severe Injuries, Including Ketoacidosis
Invokana and other related type 2 diabetes drugs have been linked to a serious condition known as ketoacidosis.
Robins Kaplan LLP Attorney Holly Dolejsi Appointed to Plaintiffs’ Steering Committee for the Invokana Multidistrict
Judge Brian R. Martinotti of the District of New Jersey entered an order on Jan. 24 appointing Holly Dolejsi to the Plaintiffs’ Steering Committee for the Invokana multidistrict litigation.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.